Xu Ling, Qu Xiujuan, Li Heming, Li Ce, Liu Jing, Zheng Huachuan, Liu Yunpeng
Department of Medical Oncology, The First Hospital of China Medical University, Heping, Shenyang 110001, P.R. China.
Cancer Research Center, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, Liaoning 121001, P.R. China.
Oncol Rep. 2014 Jul;32(1):318-24. doi: 10.3892/or.2014.3183. Epub 2014 May 15.
Gastric cancer cells are insensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), and we recently showed that lipid raft-regulated epidermal growth factor receptor (EGFR) activation antagonized TRAIL-induced apoptosis. However, it is not clear whether caveolin-1, an essential structural constituent of lipid rafts, regulates lipid raft-mediated EGFR activation. We report here that TRAIL induced the translocation of EGFR into lipid rafts and its activation in gastric cancer SGC-7901 and MGC-803 cells. Simultaneously, caveolin-1 was also activated. Knockdown of caveolin-1 partially prevented EGFR activation and increased TRAIL sensitivity. Moreover, TRAIL promoted the translocation of Src into lipid rafts and its activation, as well as the interaction of Src with both EGFR and caveolin-1. A Src inhibitor prevented these interactions and the activation of caveolin-1 and EGFR, and thus enhanced TRAIL-induced apoptosis. These data suggest that Src activates EGFR through the interaction of both Src-EGFR and Src-caveolin-1, and then antagonizes TRAIL-induced apoptosis in gastric cancer cells.
胃癌细胞对肿瘤坏死因子相关凋亡诱导配体(TRAIL)不敏感,我们最近发现脂筏调节的表皮生长因子受体(EGFR)激活可拮抗TRAIL诱导的凋亡。然而,脂筏的重要结构成分小窝蛋白-1是否调节脂筏介导的EGFR激活尚不清楚。我们在此报告,TRAIL诱导EGFR易位至脂筏并在胃癌SGC-7901和MGC-803细胞中激活。同时,小窝蛋白-1也被激活。敲低小窝蛋白-1可部分阻止EGFR激活并增加TRAIL敏感性。此外,TRAIL促进Src易位至脂筏并激活,以及Src与EGFR和小窝蛋白-1的相互作用。Src抑制剂可阻止这些相互作用以及小窝蛋白-1和EGFR的激活,从而增强TRAIL诱导的凋亡。这些数据表明,Src通过Src-EGFR和Src-小窝蛋白-1的相互作用激活EGFR,进而拮抗TRAIL诱导的胃癌细胞凋亡。